{"id":53,"title":"ER agonism leading to reduced survival due to renal failure","short_name":"ER agonism : reduced survival","created_at":"2016-11-29T18:41:16.000-05:00","updated_at":"2023-09-25T16:26:47.000-04:00","corresponding_author":{"id":17712,"created_at":"2023-09-11T18:10:58.000-04:00","updated_at":"2023-09-11T18:10:58.000-04:00","subscribed":true,"novice":null},"aop_stressors":[],"aop_mies":[{"event_id":111,"event":"Agonism, Estrogen receptor","event_type":"MolecularInitiatingEvent"}],"aop_kes":[{"event_id":418,"event":"Increased, Vitellogenin synthesis","event_type":"KeyEvent"},{"event_id":220,"event":"Increase, Plasma vitellogenin concentrations","event_type":"KeyEvent"},{"event_id":419,"event":"Increased, renal vitellogenin deposition","event_type":"KeyEvent"},{"event_id":421,"event":"Increased, glomerular rupture and renal hemorrhaging","event_type":"KeyEvent"},{"event_id":422,"event":"Increased, nephropathy","event_type":"KeyEvent"}],"aop_aos":[],"relationships":[]}